Fortis and Agilus expand rapid genomic testing capabilities
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
Experts discussed the latest innovations, challenges, & collaborative solutions in the fight against TB at NHWIC-2024 held at AIIMS, Delhi
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
Bridging the gap between histopathology and molecular pathology
Subscribe To Our Newsletter & Stay Updated